Time to Retire Enzyme-Inducing Antiseizure Meds to Cut CVD Risk? Time to Retire Enzyme-Inducing Antiseizure Meds to Cut CVD Risk?

Long-term use of enzyme-inducing antiseizure medications may increase incident cardiovascular disease risk in patients with epilepsy, prompting calls by some neurologists to retire the drugs.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news